B GROUP, INC. enters RETENSION PHARMACEUTICALS, INC. with 833.33K shares across direct and indirect positions
This filing by B GROUP, INC. establishes the baseline for all future Form 4 insider transaction reports at RETENSION PHARMACEUTICALS, INC..
Indirect
Filed: 10/16/2026ACC: 0001213900-26-110379
10% Owner
Since Oct 2026
833.33K
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
833.33K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned833.33K
Total
833.33K indirect833.33K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 833.33K | Indirect |
| Total | 833.33K | 833.33K indirect |
Derivative Holdings0
No derivative holdings reported